tech talk
“BD continues to receive
overwhelming response in India”
“
The BD FACSCelesta
allows researchers to
benefit from new innovations
in instrument and reagent
technology. They can now,
with improved brightness
and low spectral overlap,
characterize, and resolve
even dim staining
populations of interest.
26
BioVoiceNews | May 2016
The return of bioscientists back to
India is helping strengthen
research and drug pipeline, feels
Mr Robert Balderas, Vice President,
R&D, BD Biosciences. During his
recent visit to India, he shared
valuable insights on various
aspects related to flow cytometry
and BD’s recent activities with the
BioVoice
BY RAHUL KOUL
What have been your experiences so far with the ‘BD
Horizon Tour’ on teaching flow cytometry techniques in
India?
Robert: While the first tour we had here, dealt with the
development of funnel design, a high parameter one with a
range of 10-18 colours. Last year, we produced the second tour
that dealt with flow cytometry in intercellular proteins. Based
on the feedback we received from these two, we decided to come
up with the BD Horizon Tour 3. This year it was conducted at
three places in India including Delhi on April 19, then in Pune,
on April 20 at National Centre for Cell Science. Chennai hosted
it in its last leg on April 22 at Indian Institute of Technology,
Madras. And the response here was again overwhelming.
Did you provide any hands on training during the tour?
There is more focus on the education during the tours than
hands on training because of the huge number of audience we
generally have at such venues. But at the same time, we have a
large group of 10-12 application scientists in India who I believe
work with the demo boxes (flow cytometers) that will go around